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Most African trypanosomes, including the veterinary 
species Trypanosoma brucei brucei and T. congolense 
are susceptible to lysis by human serum. A recent 
study by Alsford et al. [PLoS Pathogens (2014) 10, 
e1004130] has identified a T. b. brucei lysosomal ca-
thepsin with an inhibitory effect on human serum’s 
trypanolytic action. 
 
African trypanosomes are a group of flagellated protozoan 
parasites endemic to sub-Saharan Africa. They are mostly 
non-infectious to humans, with the exception of two sub-
species, T. b. gambiense and T. b. rhodesiense, the causa-
tive agents of human African trypanosomiasis (HAT; also 
known as sleeping sickness) in west and central Africa and 
east Africa, respectively, where up to 70 million people are 
regarded as at risk. African trypanosomes, including T. b. 
brucei and T. congolense, also cause nagana, a wasting 
disease in livestock, which is thought to have stifled agri-
cultural development in the region over millennia. T. brucei 
is renowned for its ability to evade the adaptive immune 
system of its mammalian host by repeatedly replacing its 
variant surface glycoprotein (VSG) coat, a process known 
as antigenic variation. The human-infective subspecies 
have also evolved distinct mechanisms to evade human 
innate defences that normally cause rapid lysis of invading 
veterinary trypanosomes.  
Over recent years, the work of several groups, including 
those of Etienne Pays (Free University of Brussels, Bel-
gium), Stephen Hajduk (University of Georgia, USA), Jayne 
Raper (City University New York, USA) and Annette Mac-
Leod (University of Glasgow, UK), has advanced our under-
standing of the mechanisms underlying human serum-
mediated trypanolysis, and the factors that render T. b. 
gambiense and T. b. rhodesiense resistant to this attack. 
Human serum contains two trypanolytic factors, TLF1 (a 
constituent of high density lipoprotein) and TLF2 (an 
IgM/apolipoprotein-A1 complex), both of which contain 
apolipoprotein-L1 (APOL1), the trypanolytic component. T. 
brucei takes up the TLFs via receptor-mediated endocyto-
sis. In the case of TLF1, this is dependent on the interaction 
between haptoglobin-related protein, found in the com-
plex, and the trypanosome haptoglobin-haemoglobin re-
ceptor (HpHbR); it is currently unknown how TLF2 enters 
the parasite. Transit through the endocytic network brings 
TLF-APOL1 to the lysosome where the acidic pH results in a 
conformational change in APOL1, allowing it to form pores 
in the lysosomal membrane, leading to osmotic swelling 
and parasite lysis. T. b. gambiense and T. b. rhodesiense 
have evolved distinct VSG-based mechanisms to circum-
vent this lytic attack. In addition to their surface coat VSG, 
both express subspecies-specific truncated VSGs that are 
retained in the endocytic system: T. b. gambiense-specific 
glycoprotein (TgsGP) and serum-resistance associated 
(SRA) protein, respectively. SRA interacts directly with 
APOL1, blocking its access to the lysosomal membrane. In 
contrast, human serum resistance in T. b. gambiense relies 
on both gain-of-function and loss-of-function mutations. 
TgsGP is thought to stiffen the membranes of the endo-
cytic network, rendering them less susceptible to attack by 
APOL1, but resistance also depends on reduced TLF1 up-
take by TbHpHbR, due to a single amino acid substitution.  
While it’s known how TLF1 enters African trypano-
somes, how APOL1 kills the parasite, and how the human-
infective subspecies are able to resist human serum lysis, 
there are still significant gaps in our understanding of this 
process. For example, what components of the endocytic 
system are responsible for transiting TLF to the lysosome, 
and how does TLF2 enter the parasite? Other than HpHbR, 
what else makes T. b. brucei susceptible to lysis by human 
serum, and could changes in these factors represent alter-
native routes to resistance? The recent development of a 
bloodstream-form T. b. brucei RNA interference library 
enabled the identification of a complex network of pro-
teins required for the receptor-mediated endocytosis of 
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the anti-HAT drug, suramin. Selection of the RNAi library 
with human serum was expected to identify a similarly 
complex set of proteins responsible for transit of the mas-
sive (>0.5 MDa) TLF complexes through the parasite’s en-
docytic system to the lysosome. Perhaps surprisingly, only 
four proteins were identified in the screen, including the 
previously characterised HpHbR and a lysosomal mem-
brane protein, p67, already known to influence sensitivity 
to human serum, as well as inhibitor of cysteine peptidase 
(ICP) and a putative channel protein. Only one of these 
proteins, p67, promotes both suramin efficacy and human 
serum sensitivity, highlighting the importance of the lyso-
some to the action of both toxins, but also revealing that 
their successful transit through the parasite’s endocytic 
system and efficacy are dependent on different cohorts of 
proteins.  
The identification of ICP highlighted the potential role 
of trypanosome cysteine peptidases in resisting trypanoly-
sis by human serum. Targeted RNAi knockdown of the two 
T. b. brucei cathepsins, CATB and CATL, in icp null parasites 
revealed that CATL, but not CATB, could influence human 
serum sensitivity, though only in the absence of ICP. Intri-
guingly, in the presence of ICP, knockdown of CATL had no 
effect on parasite sensitivity to human serum, indicating 
that ICP’s repressive action is modulated in response to 
CATL activity. At present, how CATL influences trypanolysis 
is unclear; there are several possibilities (Figure 1). As in 
other eukaryotes, CATL localises to the lysosome in T. b. 
brucei, where the low pH promotes its activity. The pepti-
dase may target TLF-APOL1, free APOL1, or both, once they 
reach the lysosome, though the relative sensitivity of 
APOL1 and the TLFs to CATL-mediated proteolysis is un-
known. One possibility is that being embedded within a TLF 
complex affords APOL1 some protection from attack. It has 
been proposed that the TLF particle interacts with the lyso-
somal membrane, enabling the membrane integration of 
the constituent APOL1, and thereby limiting the amount of 
free APOL1 in the lysosome. In this situation, additional 
CATL activity may lead to TLF disruption and release of 
APOL1, exposing it to proteolysis by CATL or other lysoso-
mal factors. It should be noted, however, that even in the 
absence of ICP, and in the presence of presumably fully 
active CATL, T. b. brucei is still highly sensitive to human 
serum, with an EC50 of ~0.002% compared to ~0.00025% 
for wild-type parasites. Clearly, release of CATL from the 
inhibitory influence of ICP by itself is insufficient to fully 
block APOL1’s assault on the parasite’s lysosomal mem-
brane. However, in a parasite like T. b. gambiense, where 
TLF1 uptake is already significantly reduced and lysosomal 
membranes may be less susceptible due to the action of 
TgsGP, such a relatively small drop in sensitivity may be all 
that’s required to make the final step to being fully re-
sistant to human serum.  
The identification of only four proteins that make a sig-
nificant contribution to the human serum sensitivity of T. 
b. brucei, suggests that the routes to human serum re-
sistance available to this parasite are very limited. Howev-
er, it seems unlikely that human serum sensitivity in T. b. 
brucei is influenced only by these four proteins. For exam-
ple, there is likely a network of proteins involved in deter-
mining lysosomal pH, a property that is critical for the ac-
tion of APOL1. Although many of these proteins may be 
essential for parasite survival, at least representatives of 
this group would have been expected to have emerged 
following selection of the bloodstream form T. b. brucei 
RNAi library in human serum. Indeed, the presence of short 
RNAi fragments in the library, which typically result in lim-
ited knockdown, has allowed the contribution to toxin effi-
cacy of otherwise essential proteins to be identified in pre-
vious screens. Following selection of the RNAi library in 
human serum, the outputs were dominated by HpHbR 
(representing more than 73% of all mapped reads), the loss 
of which is known to render T. b. brucei highly resistant to 
trypanolysis. Therefore, factors whose depletion only pro-
FIGURE 1: Speculations on the 
interactions between TLF, APOL1 
and CATL, and a possible role for 
the putative channel protein, 
Tb927.8.5240. TLF1 is known to 
enter T. b. brucei via HpHbR at the 
flagellar pocket membrane, and 
then transit to the lysosome where 
the lytic component, APOL1, forms 
pores in the lysosomal membrane 
leading to osmotic swelling and 
parasite lysis. The mechanism for 
TLF2 entry is unknown, though it 
has been speculated that it may 
interact with surface VSG, which is 
rapidly endocytosed. The putative 
channel protein, Tb927.8.5240, 
represents a possible alternative 
uptake mechanism; however, the localisation detailed above is speculative. It is unknown whether or where within the endocytic network 
APOL1 dissociates from TLF. CATL is presumed to act upon either the lytic complexes or APOL1 in the lysosome, as its activity is dependent 
upon the acidic pH found in this organelle. Reduced human serum sensitivity is due to ‘loss-of-function’ (Green) or ‘gain-of-function’ (Blue); 
the latter includes SRA and TgsGP, which have been omitted for clarity (see main text for details).  
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vides a marginal advantage to treated parasites, but which 
still make a significant contribution to TLF-APOL1 activity, 
may be out-competed by those depleted for HpHbR. Se-
lecting the bloodstream-form T. b. brucei RNAi library with 
purified TLF2 or recombinant human APOL1, thereby pre-
venting the selection of parasites depleted for HpHbR, 
should enable the identification of parasite factors respon-
sible for TLF2 uptake and lysosomal pH regulation, respec-
tively. It will be intriguing to see what more these screens 
reveal about the role of T. b. brucei proteins in the promo-
tion of human serum trypanolysis.  
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